Walleye Capital’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
Other funds holding GPCR
BBA
Walleye Capital's GPCR Position: Q3 2026 in Review
Walleye Capital opened a new position in Structure Therapeutics (GPCR) in Q3 2026: 118,391 shares worth $3.7M. The stake represents ﹤0.01% of the portfolio and ranks #2211 among its holdings. This is a return to the name: Walleye Capital previously reported a position in GPCR as recently as Q1 2026.
Walleye Capital first reported a position in GPCR in Q1 2024 and has held it in 8 quarters since. The position peaked at $4.02M in Q1 2024. 170 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.
- Walleye Capital held 118,391 shares of Structure Therapeutics worth $3.7M as of Q3 2026.
- Structure Therapeutics was a new Walleye Capital position in Q3 2026.
- Structure Therapeutics made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2211 holding.
- Walleye Capital first reported a position in Structure Therapeutics in Q1 2024 and has held it in 8 quarters since.
- Walleye Capital's Structure Therapeutics position peaked at $4.02M in Q1 2024.
- 170 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.